Document Detail

Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial.
MedLine Citation:
PMID:  23187956     Owner:  NLM     Status:  Publisher    
Background/objectives:Cardiovascular disease (CVD) is the leading cause of death in the United States and the world. Clinical trials have suggested that soybean protein lowers lipids and blood pressure. The effect of soybean protein on novel CVD risk factors has not been well studied. The objective of this study was to examine the effect of soybean protein on biomarkers of inflammation, endothelial dysfunction and adipocytokines.Subjects/methods:The effect of 8 weeks of 40 g of soybean protein supplement (89.3 mg isoflavones), 40 g of milk protein supplement and 40 g of complex carbohydrate placebo was examined in a randomized, placebo-controlled, double-blind, three-phase crossover trial among adults in New Orleans, Louisiana and Jackson, Mississippi. Plasma levels of inflammation biomarkers (C-reactive protein, interleukin-6, tumor necrosis factor-α), endothelial dysfunction biomarkers (E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, thrombomodulin) and adipocytokines (high-molecular weight adiponectin, leptin, resistin) were measured at baseline and at the end of each intervention using immunoturbidimetric and enzyme-linked immunosorbent assay techniques.Results:Soy protein supplementation resulted in a significant mean net change (95% confidence interval) in plasma E-selectin of -3.93 ng/ml (-7.05 to -0.81 ng/ml; P=0.014) compared with milk protein, and in plasma leptin of -2089.8 pg/ml (-3689.3 to -490.3 pg/ml; P=0.011) compared with carbohydrate. There were no significant changes in any other risk factors.Conclusions:Soy protein supplementation may reduce levels of E-selectin and leptin. Further research is warranted to investigate the mechanisms through which protein may confer protective effects on novel CVD risk factors.European Journal of Clinical Nutrition advance online publication, 28 November 2012; doi:10.1038/ejcn.2012.186.
C M Rebholz; K Reynolds; M R Wofford; J Chen; T N Kelly; H Mei; P K Whelton; J He
Related Documents :
23621606 - Structure and flexibility of nanoscale protein cages designed by symmetric self-assembly.
23144756 - Structural insight into the clostridium difficile ethanolamine utilisation microcompart...
24410546 - Anions in electrothermal supercharging of proteins with electrospray ionization follow ...
25276096 - Two dimensional gel phosphoproteome of peripheral blood mononuclear cells: comparison b...
19137546 - A comprehensive evaluation of imidazole-zinc reverse stain for current proteomic resear...
2753226 - Phosphorylation of proteins in rat ovarian plasma membranes by [gamma-32p]gtp: evidence...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-28
Journal Detail:
Title:  European journal of clinical nutrition     Volume:  -     ISSN:  1476-5640     ISO Abbreviation:  Eur J Clin Nutr     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804070     Medline TA:  Eur J Clin Nutr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomiz...
Next Document:  Ruthenium(ii) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.